Cargando…
Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells
Recent studies highlight immunoregulatory functions of type I interferons (IFN-I) during the pathogenesis of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We demonstrated that selective activation of IFN-I pathways including RIG-I/MAVS and cGA...
Autores principales: | Fischer, Julius C., Bscheider, Michael, Göttert, Sascha, Thiele Orberg, Erik, Combs, Stephanie E., Bassermann, Florian, Heidegger, Simon, Haas, Tobias, Poeck, Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800427/ https://www.ncbi.nlm.nih.gov/pubmed/31628411 http://dx.doi.org/10.1038/s41598-019-51431-2 |
Ejemplares similares
-
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
por: Joachim, Laura, et al.
Publicado: (2023) -
Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021) -
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
por: Heidegger, Simon, et al.
Publicado: (2019) -
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022) -
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy
por: Heidegger, Simon, et al.
Publicado: (2023)